May 26, 2021
Avisa Diagnostics Inc. (CSE:AVBT) (Avisa), a clinical-stage medical device company developing an ultra-rapid, point-of-care biomarker[...]
May 18, 2021
Avisa Diagnostics Inc. (Avisa) is pleased to announce that the Company has begun trading on the Canadian Securites Exchange (CSE:AVBT)[...]
May 4, 2021
Avisa Diagnostics Inc. (formerly, FogChain Corp.) (the “Company”) is pleased to announce the closing of its previously announced[...]
February 4, 2020
Avisa Pharma Inc. (“AVISA” or “the Company”), a medical device company developing a drug/device biomarker technology platform[...]
September 18, 2018
Ten-minute, point-of-care breath test rapidly detects virulent bacterial infections to mitigate overuse of antibiotics and save[...]

Subscribe to receive our press releases

Stock Info:
CSE:   AVBT $0.00